Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Diseases

Explore clinical trials studying Gastrointestinal Diseases. Study availability and eligibility vary by location and protocol.

18,028 public trials 3,511 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Diseases trial results

Recruiting

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

NCT05503797

Conditions
Adenocarcinoma, Adnexal Diseases, Biliary Tract Diseases, +52 more
Locations
  • Precision NextGen Oncology & Research Center Beverly Hills, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of California Los Angeles Rheumatology Westwood, Los Angeles, California, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 70 locations
View Trial Details
Recruiting

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

NCT06465069

Conditions
Adnexal Diseases, Advanced Solid Tumor, Bladder Cancer, +72 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • University of California, San Diego (UCSD) - Moores Cancer Center La Jolla, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthOne Denver, Colorado, United States
View all 38 locations
View Trial Details
Recruiting

Helicobacter Pylori Infection Status and Pathological Features for Predicting Gastric Cancer Biological Behavior and Prognosis: A Real-World Observational Study

NCT07724496

Conditions
Digestive System Diseases, Digestive System Neoplasms, Early Gastric Cancer, +7 more
Locations
  • The Eighth Medical Center of Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • First Medical Center of Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • Department of Gastroenterology, Rocket Force Characteristic Medical Center Beijing, Beijing Municipality, China
View Trial Details
Recruiting

Study on the Efficacy and Safety of Neoadjuvant Radiotherapy Combined With Tislelizumab, Liposomal Irinotecan, and Capecitabine in the Treatment of pMMR Locally Advanced Rectal Adenocarcinoma With Low Rectal Involvement

NCT07104604

Conditions
Colorectal Neoplasms, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Shantou University Medical College Cancer Hospital Shantou, Guangdong, China
  • The First Affiliated Hospital of Shantou University Medical College Shantou, Guangdong, China
View Trial Details

Related conditions